Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
8.30
+0.37 (4.67%)
At close: Jan 21, 2026, 4:00 PM EST
8.25
-0.05 (-0.60%)
After-hours: Jan 21, 2026, 7:51 PM EST
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $754.39 million as of January 21, 2026. Its market cap has decreased by -26.75% in one year.
Market Cap
754.39M
Enterprise Value
695.51M
1-Year Change
-26.75%
Ranking
Category
Stock Price
$8.30
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $754.39M, an increase of 46.37%. That is a compound annual growth rate of 18.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 720.76M | 12.32% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |